Abstract:Smoking is a major risk factor for a variety of diseases, including cancer and immune-mediated inflammatory diseases. Tobacco smoke contains a mixture of chemicals, including a host of reactive oxygen- and nitrogen species (ROS and RNS), among others, that can damage cellular and sub-cellular targets, such as lipids, proteins, and nucleic acids. A growing body of evidence supports a key role for smoking-induced ROS and the resulting oxidative stress in inflammation and carcinogenesis. This comprehensive and up-to-date review covers four interrelated topics, including 'smoking', 'oxidative stress', 'inflammation', and 'cancer'. The review discusses each of the four topics, while exploring the intersections among the topics by highlighting the macromolecular damage attributable to ROS. Specifically, oxidative damage to macromolecular targets, such as lipid peroxidation, post-translational modification of proteins, and DNA adduction, as well as enzymatic and non-enzymatic antioxidant defense mechanisms, and the multi-faceted repair pathways of oxidized lesions are described. Also discussed are the biological consequences of oxidative damage to macromolecules if they evade the defense mechanisms and/or are not repaired properly or in time. Emphasis is placed on the genetic- and epigenetic alterations that may lead to transcriptional deregulation of functionally-important genes and disruption of regulatory elements. Smoking-associated oxidative stress also activates the inflammatory response pathway, which triggers a cascade of events of which ROS production is an initial yet indispensable step. The release of ROS at the site of damage and inflammation helps combat foreign pathogens and restores the injured tissue, while simultaneously increasing the burden of oxidative stress. This creates a vicious cycle in which smoking-related oxidative stress causes inflammation, which in turn, results in further generation of ROS, and potentially increased oxidative damage to macromolecular targets that may lead to cancer initiation and/or progression.

Smoking and Atherosclerosis: Mechanisms of Disease and New Therapeutic Approaches

Oxidative stress and inflammation: elucidating mechanisms of smoking-attributable pathology for therapeutic targeting

Pathophysiologic Mechanisms of Tobacco Smoke Producing Atherosclerosis

The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis

Smoking and the Pathophysiology of Peripheral Artery Disease

Cigarette Smoking and Adipose Tissue: the Emerging Role in Progression of Atherosclerosis

Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm

The peripheral vascular consequences of smoking

The Hidden Dangers: E-Cigarettes, Heated Tobacco, and Their Impact on Oxidative Stress and Atherosclerosis—A Systematic Review and Narrative Synthesis of the Evidence

Nicotine in Senescence and Atherosclerosis

Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review

Cigarette smoking associated with advanced periodontal destruction in a Greek sample population of patients with periodontal disease

Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products

Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer

Modern Trends in the Influence of Passive Smoking on Atherosclerosis

Ocular conditions and dry eye due to traditional and new forms of smoking: A review

Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes

[Smoking and the skin]

Advancements in Cardiovascular Disease Research Affected by Smoking

Active and Passive Smoking, Chronic Infections, and the Risk of Carotid Atherosclerosis

Smoking-induced microbial dysbiosis in health and disease